EZH2 as a potential therapeutic target for gastrointestinal cancers-Reference-Cited by-同舟云学术

EZH2 as a potential therapeutic target for gastrointestinal cancers

Published:2024-01 Issue: Volume:253 Page:154988
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Hashemi Mehrdad,Nazdari Naghmeh,Gholamiyan Ghazaleh,Paskeh Mahshid Deldar Abad,Jafari Ali Moghadas,Nemati Fateme,Khodaei Elaheh,Abyari Ghazal,behdadfar Nazanin,Raei Behnaz,Raesi Rasoul,Nabavi Noushin,Hu Peng,Rashidi Mohsen,Taheriazam Afshin,Entezari Maliheh

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference258 articles.

1. The matrix in cancer;Cox;Nat. Rev. Cancer,2021

2. Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma;Fathi;Mol. Biol. Rep.,2021

3. The therapeutic potential of common herbal and nano-based herbal formulations against ovarian cancer: New insight into the current evidence;Rezaei-Tazangi;Pharmaceuticals,2021

4. Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy;Meybodi;J. Funct. Foods,2023

5. Mesenchymal stem cells and ovarian cancer: Is there promising news?;Jahani;J. Cell. Biochem.,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target EZH2 inhibitor: latest advances in medicinal chemistry;Future Medicinal Chemistry;2024-07-31

2. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells;Biomolecules;2024-04-05